These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 15270592

  • 1. Prescribing antiepileptic drugs: should patients be switched on the basis of cost?
    Jobst BC, Holmes GL.
    CNS Drugs; 2004; 18(10):617-28. PubMed ID: 15270592
    [Abstract] [Full Text] [Related]

  • 2. Generic products of antiepileptic drugs (AEDs): is it an issue?
    Bialer M.
    Epilepsia; 2007 Oct; 48(10):1825-32. PubMed ID: 17850324
    [Abstract] [Full Text] [Related]

  • 3. Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes.
    Andermann F, Duh MS, Gosselin A, Paradis PE.
    Epilepsia; 2007 Mar; 48(3):464-9. PubMed ID: 17346246
    [Abstract] [Full Text] [Related]

  • 4. The clinical effectiveness and cost-effectiveness of newer drugs for children with epilepsy. A systematic review.
    Connock M, Frew E, Evans BW, Bryan S, Cummins C, Fry-Smith A, Li Wan Po A, Sandercock J.
    Health Technol Assess; 2006 Mar; 10(7):iii, ix-118. PubMed ID: 16545206
    [Abstract] [Full Text] [Related]

  • 5. Recommendations of the Italian League against Epilepsy working group on generic products of antiepileptic drugs.
    Perucca E, Albani F, Capovilla G, Bernardina BD, Michelucci R, Zaccara G.
    Epilepsia; 2006 Mar; 47 Suppl 5():16-20. PubMed ID: 17239100
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population.
    Davis KL, Candrilli SD, Edin HM.
    Epilepsia; 2008 Mar; 49(3):446-54. PubMed ID: 18031549
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparing healthcare cost associated with the use of enzyme-inducing and non-enzyme active antiepileptic drugs in elderly patients with epilepsy in the UK: a long-term retrospective, matched cohort study.
    Borghs S, Byram L, Chan J, Dedeken P, Logan J, Kiri V, Noack-Rink M, Patsalos PN, Thieffry S.
    BMC Neurol; 2020 Jan 08; 20(1):7. PubMed ID: 31914953
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of costs of epilepsy using an electronic practice management software in Germany.
    Noda AH, Hermsen A, Berkenfeld R, Dennig D, Endrass G, Kaltofen J, Safavi A, Wiehler S, Carl G, Meier U, Elger CE, Menzler K, Knake S, Rosenow F, Strzelczyk A.
    Seizure; 2015 Mar 08; 26():49-55. PubMed ID: 25799902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.